| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2013PLoSO...856667Y |
| P356 | DOI | 10.1371/JOURNAL.PONE.0056667 |
| P932 | PMC publication ID | 3584057 |
| P698 | PubMed publication ID | 23460808 |
| P5875 | ResearchGate publication ID | 235788012 |
| P2093 | author name string | Tai-Lung Cha | |
| Cheng-Ping Yu | |||
| Dah-Shyong Yu | |||
| Fung-Wei Chang | |||
| Guang-Huan Sun | |||
| Jar-Yi Ho | |||
| Ren-Jun Hsu | |||
| Shu-Pin Chen | |||
| Yi-Ting Huang | |||
| P2860 | cites work | Acquired renal cystic disease: implications for the urologist | Q37717142 |
| von Hippel-Lindau disease affecting 43 members of a single kindred | Q38596547 | ||
| Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells | Q39852846 | ||
| Expression of estrogen receptor beta in prostate carcinoma cells inhibits invasion and proliferation and triggers apoptosis | Q40555061 | ||
| Reduced expression of oestrogen receptor β in invasive breast cancer and its re‐expression using DNA methyl transferase inhibitors in a cell line model | Q40630217 | ||
| Oestrogen-induced apoptosis in colonocytes expressing oestrogen receptor beta | Q40707148 | ||
| Estrogen receptor beta is expressed in human colorectal adenocarcinoma | Q40779002 | ||
| Estrogen receptor-beta is expressed in Barrett's metaplasia and associated adenocarcinoma of the esophagus | Q44095205 | ||
| Estrogen receptor-beta affects the prognosis of human malignant mesothelioma | Q44403512 | ||
| Tumor repressive functions of estrogen receptor beta in SW480 colon cancer cells. | Q53383716 | ||
| Co-existence of high levels of the PTEN protein with enhanced Akt activation in renal cell carcinoma. | Q53535998 | ||
| Estrogen receptor beta is expressed in human stomach adenocarcinoma | Q74320813 | ||
| Expression of estrogen receptor-beta isoforms in Barrett's metaplasia, dysplasia and esophageal adenocarcinoma | Q80940040 | ||
| Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis | Q24310597 | ||
| Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death | Q24312211 | ||
| The epidemiology of renal cell carcinoma | Q28272382 | ||
| Mitochondria and apoptosis | Q29547905 | ||
| ERbeta in breast cancer--onlooker, passive player, or active protector? | Q30438399 | ||
| Matrix metalloproteinases: a tail of a frog that became a prince | Q33337157 | ||
| The pro-apoptotic effect of quercetin in cancer cell lines requires ERβ-dependent signals. | Q34197932 | ||
| Searching for the hereditary causes of renal-cell carcinoma | Q34318015 | ||
| Cytoplasmic sequestration of p27 via AKT phosphorylation in renal cell carcinoma. | Q34536470 | ||
| Estimates of the cancer incidence and mortality in Europe in 2006. | Q34575047 | ||
| Estrogen receptor β represses Akt signaling in breast cancer cells via downregulation of HER2/HER3 and upregulation of PTEN: implications for tamoxifen sensitivity | Q35559028 | ||
| Distinct expression patterns of ER alpha and ER beta in normal human mammary gland | Q35586151 | ||
| Apoptosis-modulating agents in combination with radiotherapy-current status and outlook | Q35642871 | ||
| Matrix metalloproteinases as therapeutic targets in cancer | Q36126571 | ||
| Regulated targeting of BAX to mitochondria. | Q36255507 | ||
| Common and uncommon histologic subtypes of renal cell carcinoma: imaging spectrum with pathologic correlation | Q36652745 | ||
| Malignant renal tumors in tuberous sclerosis | Q37690179 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | estrogen | Q277954 |
| renal cell carcinoma | Q1164529 | ||
| P304 | page(s) | e56667 | |
| P577 | publication date | 2013-02-27 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Estrogen inhibits renal cell carcinoma cell progression through estrogen receptor-β activation | |
| P478 | volume | 8 |
| Q38997922 | 17β-Estradiol inhibition of IL-6-Src and Cas and paxillin pathway suppresses human mesenchymal stem cells-mediated gastric cancer cell motility |
| Q41583763 | Activation of G Protein Coupled Estrogen Receptor (GPER) Promotes the Migration of Renal Cell Carcinoma via the PI3K/AKT/MMP-9 Signals |
| Q35182934 | Age-dependent association between sex and renal cell carcinoma mortality: a population-based analysis |
| Q90941500 | Association between age and sex and mortality after adjuvant therapy for renal cancer |
| Q37294496 | Cellular effects induced by 17-β-estradiol to reduce the survival of renal cell carcinoma cells. |
| Q37582438 | Comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificity |
| Q38773922 | Cyclic Ketoximes as Estrogen Receptor β Selective Agonists. |
| Q40401994 | DNA repair system and renal cell carcinoma prognosis: under the influence of NBS1. |
| Q57074559 | Estrogen affects cell growth and IGF-1 receptor expression in renal cell carcinoma |
| Q42655390 | Estrogen receptor β exhibited anti-tumor effects on osteosarcoma cells by regulating integrin, IAP, NF-kB/BCL-2 and PI3K/Akt signal pathway |
| Q57165695 | Estrogen receptor β promotes renal cell carcinoma progression via regulating LncRNA HOTAIR-miR-138/200c/204/217 associated CeRNA network |
| Q34315419 | Estrogen receptors alpha (ERα) and beta (ERβ): subtype-selective ligands and clinical potential. |
| Q40905617 | Estrogen suppresses hepatocellular carcinoma cells through ERβ-mediated upregulation of the NLRP3 inflammasome. |
| Q53733289 | Evaluation of steroid hormones and their receptors in development and progression of renal cell carcinoma. |
| Q92646666 | Expression and localization of estrogen receptors in human renal cell carcinoma and their clinical significance |
| Q38372445 | Future perspectives for mTOR inhibitors in renal cell cancer treatment |
| Q38599201 | Gender differences in incidence and outcomes of urothelial and kidney cancer |
| Q38765612 | Gene set enrichment analysis and ingenuity pathway analysis of metastatic clear cell renal cell carcinoma cell line |
| Q36589182 | Generation of an estrogen receptor beta-iCre knock-in mouse |
| Q37261206 | Genistein potentiates the effect of 17-beta estradiol on human hepatocellular carcinoma cell line |
| Q42345523 | Genitourinary malignancies in India: Laying the foundations for the future |
| Q36099567 | HDAC 1 and 6 modulate cell invasion and migration in clear cell renal cell carcinoma |
| Q35858096 | High ERα36 Expression Level and Membrane Location Predict Poor Prognosis in Renal Cell Carcinoma |
| Q36175547 | Highly selective salicylketoxime-based estrogen receptor β agonists display antiproliferative activities in a glioma model |
| Q38848220 | Identification of genes associated with renal cell carcinoma using gene expression profiling analysis |
| Q64981024 | Impact of Estrogen on the Relationship Between Obesity and Renal Cell Carcinoma Risk in Women. |
| Q37607736 | Impact of Gender in Renal Cell Carcinoma: The Relationship of FABP7 and BRN2 Expression with Overall Survival |
| Q36326380 | Infiltrating neutrophils promote renal cell carcinoma progression via VEGFa/HIF2α and estrogen receptor β signals |
| Q92568894 | Interstitial chromosomal deletion of the tuberous sclerosis complex 2 locus is a signature for radiation-associated renal tumors in Eker rats |
| Q34769797 | Oral contraceptive use and kidney cancer risk among women: evidence from a meta-analysis |
| Q90750222 | Potential Therapeutic Application of Estrogen in Gender Disparity of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis |
| Q64981111 | Potential role of estradiol in ovariectomy-induced derangement of renal endocrine functions. |
| Q34524093 | Selective Estrogen Receptor β Agonist LY500307 as a Novel Therapeutic Agent for Glioblastoma |
| Q38808593 | Sexual dimorphism in cancer |
| Q59349492 | Sexual dimorphism in hepatitis B and C and hepatocellular carcinoma |
| Q58563693 | Sexual dimorphism in solid and hematological malignancies |
| Q38818360 | Silencing Estrogen Receptor-β with siRNA in Cultured Cells |
| Q35599990 | Structural and Functional Diversity of Estrogen Receptor Ligands |
| Q44782509 | Update on the therapeutic significance of estrogen receptor beta in malignant gliomas |
| Q36353532 | Vitamin C intake and risk of renal cell carcinoma: a meta-analysis |
Search more.